105 related articles for article (PubMed ID: 30837833)
1.
Tan M; Li J; Ma F; Zhang X; Zhao Q; Cao X
Front Neurosci; 2019; 13():116. PubMed ID: 30837833
[TBL] [Abstract][Full Text] [Related]
2. Rare Variants in PLD3 Increase Risk for Alzheimer's Disease in Han Chinese.
Tan MS; Zhu JX; Cao XP; Yu JT; Tan L
J Alzheimers Dis; 2018; 64(1):55-59. PubMed ID: 29865074
[TBL] [Abstract][Full Text] [Related]
3. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.
Cruchaga C; Karch CM; Jin SC; Benitez BA; Cai Y; Guerreiro R; Harari O; Norton J; Budde J; Bertelsen S; Jeng AT; Cooper B; Skorupa T; Carrell D; Levitch D; Hsu S; Choi J; Ryten M; Sassi C; Bras J; Gibbs RJ; Hernandez DG; Lupton MK; Powell J; Forabosco P; Ridge PG; Corcoran CD; Tschanz JT; Norton MC; Munger RG; Schmutz C; Leary M; Demirci FY; Bamne MN; Wang X; Lopez OL; Ganguli M; Medway C; Turton J; Lord J; Braae A; Barber I; Brown K; ; Pastor P; Lorenzo-Betancor O; Brkanac Z; Scott E; Topol E; Morgan K; Rogaeva E; Singleton A; Hardy J; Kamboh MI; George-Hyslop PS; Cairns N; Morris JC; Kauwe JSK; Goate AM
Nature; 2014 Jan; 505(7484):550-554. PubMed ID: 24336208
[TBL] [Abstract][Full Text] [Related]
4. PLD3 in Alzheimer's disease.
Wang J; Yu JT; Tan L
Mol Neurobiol; 2015 Apr; 51(2):480-6. PubMed ID: 24935720
[TBL] [Abstract][Full Text] [Related]
5. PLD3 epigenetic changes in the hippocampus of Alzheimer's disease.
Blanco-Luquin I; Altuna M; Sánchez-Ruiz de Gordoa J; Urdánoz-Casado A; Roldán M; Cámara M; Zelaya V; Erro ME; Echavarri C; Mendioroz M
Clin Epigenetics; 2018 Sep; 10(1):116. PubMed ID: 30208929
[TBL] [Abstract][Full Text] [Related]
6. Rare Variants in PLD3 Do Not Affect Risk for Early-Onset Alzheimer Disease in a European Consortium Cohort.
Cacace R; Van den Bossche T; Engelborghs S; Geerts N; Laureys A; Dillen L; Graff C; Thonberg H; Chiang HH; Pastor P; Ortega-Cubero S; Pastor MA; Diehl-Schmid J; Alexopoulos P; Benussi L; Ghidoni R; Binetti G; Nacmias B; Sorbi S; Sanchez-Valle R; Lladó A; Gelpi E; Almeida MR; Santana I; Tsolaki M; Koutroumani M; Clarimon J; Lleó A; Fortea J; de Mendonça A; Martins M; Borroni B; Padovani A; Matej R; Rohan Z; Vandenbulcke M; Vandenberghe R; De Deyn PP; Cras P; van der Zee J; Sleegers K; Van Broeckhoven C;
Hum Mutat; 2015 Dec; 36(12):1226-35. PubMed ID: 26411346
[TBL] [Abstract][Full Text] [Related]
7. PLD3 in Alzheimer's Disease: a Modest Effect as Revealed by Updated Association and Expression Analyses.
Zhang DF; Fan Y; Wang D; Bi R; Zhang C; Fang Y; Yao YG
Mol Neurobiol; 2016 Aug; 53(6):4034-4045. PubMed ID: 26189833
[TBL] [Abstract][Full Text] [Related]
8. Excess of rare coding variants in PLD3 in late- but not early-onset Alzheimer's disease.
Schulte EC; Kurz A; Alexopoulos P; Hampel H; Peters A; Gieger C; Rujescu D; Diehl-Schmid J; Winkelmann J
Hum Genome Var; 2015; 2():14028. PubMed ID: 27081517
[TBL] [Abstract][Full Text] [Related]
9. PLD3 is accumulated on neuritic plaques in Alzheimer's disease brains.
Satoh J; Kino Y; Yamamoto Y; Kawana N; Ishida T; Saito Y; Arima K
Alzheimers Res Ther; 2014; 6(9):70. PubMed ID: 25478031
[TBL] [Abstract][Full Text] [Related]
10. V232M substitution restricts a distinct O-glycosylation of PLD3 and its neuroprotective function.
Demirev AV; Song HL; Cho MH; Cho K; Peak JJ; Yoo HJ; Kim DH; Yoon SY
Neurobiol Dis; 2019 Sep; 129():182-194. PubMed ID: 31121321
[TBL] [Abstract][Full Text] [Related]
11. PLD3 affects axonal spheroids and network defects in Alzheimer's disease.
Yuan P; Zhang M; Tong L; Morse TM; McDougal RA; Ding H; Chan D; Cai Y; Grutzendler J
Nature; 2022 Dec; 612(7939):328-337. PubMed ID: 36450991
[TBL] [Abstract][Full Text] [Related]
12. Endo-lysosomal dysregulations and late-onset Alzheimer's disease: impact of genetic risk factors.
Van Acker ZP; Bretou M; Annaert W
Mol Neurodegener; 2019 Jun; 14(1):20. PubMed ID: 31159836
[TBL] [Abstract][Full Text] [Related]
13. Unconventional Trafficking of Mammalian Phospholipase D3 to Lysosomes.
Gonzalez AC; Schweizer M; Jagdmann S; Bernreuther C; Reinheckel T; Saftig P; Damme M
Cell Rep; 2018 Jan; 22(4):1040-1053. PubMed ID: 29386126
[TBL] [Abstract][Full Text] [Related]
14. Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease.
Nho K; Kim S; Horgusluoglu E; Risacher SL; Shen L; Kim D; Lee S; Foroud T; Shaw LM; Trojanowski JQ; Aisen PS; Petersen RC; Jack CR; Weiner MW; Green RC; Toga AW; Saykin AJ;
BMC Med Genomics; 2017 May; 10(Suppl 1):29. PubMed ID: 28589856
[TBL] [Abstract][Full Text] [Related]
15. Autophagic dysfunction in Alzheimer's disease: Cellular and molecular mechanistic approaches to halt Alzheimer's pathogenesis.
Uddin MS; Mamun AA; Labu ZK; Hidalgo-Lanussa O; Barreto GE; Ashraf GM
J Cell Physiol; 2019 Jun; 234(6):8094-8112. PubMed ID: 30362531
[TBL] [Abstract][Full Text] [Related]
16. Knowledge-driven binning approach for rare variant association analysis: application to neuroimaging biomarkers in Alzheimer's disease.
Kim D; Basile AO; Bang L; Horgusluoglu E; Lee S; Ritchie MD; Saykin AJ; Nho K
BMC Med Inform Decis Mak; 2017 May; 17(Suppl 1):61. PubMed ID: 28539126
[TBL] [Abstract][Full Text] [Related]
17. Identification of rare RTN3 variants in Alzheimer's disease in Han Chinese.
Zou Y; He W; Wang K; Han H; Xiao T; Chen X; Zhou B; Tan J; Xia K; Tang B; Chen C; Shen L; Yan R; Zhang Z
Hum Genet; 2018 Feb; 137(2):141-150. PubMed ID: 29356939
[TBL] [Abstract][Full Text] [Related]
18. Integration of bioinformatics and imaging informatics for identifying rare PSEN1 variants in Alzheimer's disease.
Nho K; Horgusluoglu E; Kim S; Risacher SL; Kim D; Foroud T; Aisen PS; Petersen RC; Jack CR; Shaw LM; Trojanowski JQ; Weiner MW; Green RC; Toga AW; Saykin AJ;
BMC Med Genomics; 2016 Aug; 9 Suppl 1(Suppl 1):30. PubMed ID: 27535542
[TBL] [Abstract][Full Text] [Related]
19. Quantification and characterization of the 5' exonuclease activity of the lysosomal nuclease PLD3 by a novel cell-based assay.
Cappel C; Gonzalez AC; Damme M
J Biol Chem; 2021; 296():100152. PubMed ID: 33288674
[TBL] [Abstract][Full Text] [Related]
20. Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer's disease.
De Roeck A; Van den Bossche T; van der Zee J; Verheijen J; De Coster W; Van Dongen J; Dillen L; Baradaran-Heravi Y; Heeman B; Sanchez-Valle R; Lladó A; Nacmias B; Sorbi S; Gelpi E; Grau-Rivera O; Gómez-Tortosa E; Pastor P; Ortega-Cubero S; Pastor MA; Graff C; Thonberg H; Benussi L; Ghidoni R; Binetti G; de Mendonça A; Martins M; Borroni B; Padovani A; Almeida MR; Santana I; Diehl-Schmid J; Alexopoulos P; Clarimon J; Lleó A; Fortea J; Tsolaki M; Koutroumani M; Matěj R; Rohan Z; De Deyn P; Engelborghs S; Cras P; Van Broeckhoven C; Sleegers K;
Acta Neuropathol; 2017 Sep; 134(3):475-487. PubMed ID: 28447221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
